[Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support]
- PMID: 38332585
- PMCID: PMC10945098
- DOI: 10.37201/req/120.2023
[Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support]
Keywords: case report; extracorporeal membrane oxygenation; isavuconazole; pharmacokinetics.
Conflict of interest statement
Los autores declaran no tener ningún conflicto de intereses.
Figures
Similar articles
-
The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation.Crit Care. 2022 Jul 27;26(1):227. doi: 10.1186/s13054-022-04093-y. Crit Care. 2022. PMID: 35897020 Free PMC article. No abstract available.
-
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.Am J Health Syst Pharm. 2022 Jul 22;79(15):1245-1249. doi: 10.1093/ajhp/zxac043. Am J Health Syst Pharm. 2022. PMID: 35377411 Free PMC article.
-
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.Crit Care. 2018 Dec 22;22(1):355. doi: 10.1186/s13054-018-2285-5. Crit Care. 2018. PMID: 30577863 Free PMC article. No abstract available.
-
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):281-290. doi: 10.1007/s13318-017-0445-7. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29101732 Review.
-
[Current therapeutic options in invasive mycosis and potential therapeutic role of isavuconazole].Rev Iberoam Micol. 2018 Oct-Dec;35(4):192-197. doi: 10.1016/j.riam.2018.07.003. Epub 2018 Nov 16. Rev Iberoam Micol. 2018. PMID: 30455108 Review. Spanish.
References
-
- Zurl C, Waller M, Schwameis F, Muhr T, Bauer N, Zollner-Schwetz I, et al. . Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations. J Fungi (Basel). 2020; 6 (2): 90. 10.3390/jof6020090 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources